Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?

Currently, only according to incidence of outpatient visits, a number of patients with diabetes mellitus (DM) account for more than 300 million in the world [1]. Over 90% of these patients suffer from type 2 diabetes mellitus (DM2). It is well known that DM2 is characterized by progressive course, and its prognosis depends on the timeliness, relevance and effectiveness of prescribed therapy. Leading specialists around the world came to an agreement on the initiation of drug therapy with the debut of the disease along with diet and physical activity. As a rule, oral hypoglycemic agents (OADs) are the drugs of choice in the first stage of treatment due to their usability, potentials for maximum maintenance of patient’s habitual lifestyle, and minimal impact on the quality of life [2]. Quite often, however, inadequate attention is paid to the patient’s motivation to adjust their habits and the correct perceive the disease. Since the early days of diagnosis of DM2, it is overwhelmingly important to form a correct concept of the disease as a progressive illness that requires daily attention, dietary intervention, physical activity, drug intake and possible intensification of therapy by a combination of two or three drugs, or transition to insulin therapy. During management of the patient, it is necessary to form a partner that can and must be directly and actively involved in the treatment process not only by change of lifestyle, but through self-control.

type 2 diabetes mellitus, oral hypoglycemic agents, dipeptidyl peptidase-4 inhibitors